Otolaryngology Doctors in Frederick, MD Accepting Medicare

9 Otolaryngology doctors found. Showing 1 - 9

Michael R Morris, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 75 Thomas Johnson Dr, Suite B, Frederick, MD 21702 Phone: 301-695-3100    Fax: 301-695-7403

Holly Marie Rataiczak, D.O. Otolaryngology Medicare: Medicare Enrolled Practice Location: 75 Thomas Johnson Dr, Frederick, MD 21702 Phone: 240-215-6310

Dr. Gerald M Reed, D.O. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 163 Thomas Johnson Drive, Suite H, Frederick, MD 21702 Phone: 301-694-9111    Fax: 301-739-0402

Florence A Othieno, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 75 Thomas Johnson Dr, Frederick, MD 21702 Phone: 240-575-2526

Dr. Wayne Anthony Cardoni, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 501 W 7th St, Frederick, MD 21701 Phone: 301-663-9573

Everett T. Hart, M.D. Otolaryngology Medicare: Not Enrolled in Medicare Practice Location: 75 Thomas Johnson Dr, Ste B, Frederick, MD 21702 Phone: 301-695-3100

Dr. George Lee Coppit Iii, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 501 W 7th St, Frederick, MD 21701 Phone: 301-663-9573

Dr. James Phillip Oberman, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 501 W 7th St, Frederick, MD 21701 Phone: 240-575-2526

Dr. Jared Joseph Tompkins, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 501 W 7th St, Frederick, MD 21701 Phone: 240-575-2526    Fax: 240-439-8910

News Archive

Abbott announces research confirming presence of lutein in key regions of the infant brain

Preliminary new research demonstrates for the first time that lutein, an important phytonutrient (plant-based nutrient) that supports eye health, is the predominant carotenoid present in key areas of the infant brain, including areas that regulate overall brain function, cognition, vision, hearing and speech. This new research, supported by Abbott, was presented by Elizabeth Johnson, PhD, a scientist in the Carotenoids and Health Laboratory at Tufts University, at the 16th International Symposium on Carotenoids, in Krakow, Poland.

Endo International announces pricing of $1.635 billion aggregate principal amount of 6.00% senior notes

Endo International plc today announced that Endo Limited, Endo Finance LLC and Endo Finco Inc. (collectively, the "Issuers"), its wholly-owned subsidiaries, priced $1.635 billion aggregate principal amount of 6.00% senior notes due July 2023 at an issue price of $1,000 per $1,000 principal amount in connection with their previously announced private offering.

New research shows that time-based intervention can improve self-control

A study conducted by researchers at Kansas State University is the first to demonstrate increases in both self-control and timing precision as a result of a time-based intervention. This new research may be an important clue for developing behavioral approaches to treat disorders like attention deficit hyperactivity disorder, substance abuse and obesity.

NASDAQ issues deficiency letter to Commonwealth Biotechnologies, grants grace period upto March 15, 2010

Commonwealth Biotechnologies, Inc. ("CBI" or "Company")) (NASDAQ Capital Market:CBTE) today announced that on September 15, 2009, CBI received a letter from The NASDAQ Stock Market indicating that the bid price of the Company's common stock had closed below the minimum $1.00 per share threshold set forth in NASDAQ Listing Rule 5550(a)(2) for the prior 30 consecutive business days.

Read more Medical News

› Verified 8 days ago